Lundbeck profit jumps but warns on generic pressure
Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.
Medications
May 01, 2013 |
not rated yet |
0
Are human genes patentable?
(Medical Xpress)—On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, "Under what conditions, if any, ...
Genetics
Apr 11, 2013 |
4.3 / 5 (6) |
16
|
Drug maker Novartis loses India patent battle (Update)
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world ...
Medications
Apr 01, 2013 |
5 / 5 (3) |
0
Big Pharma battle threatens to delay Pacific trade pact
A US-led Pacific free trade pact faces further delays as a row between Big Pharma and activists supporting access to generic drugs erupts ahead of an October deadline, officials say.
Medications
Mar 10, 2013 |
not rated yet |
1
Pfizer painkiller gets longer patent protection (Update)
Drugmaker Pfizer Inc. said Tuesday that a new patent on one of its top drugs, anti-inflammatory painkiller Celebrex, extends its U.S. patent protection by 18 months, potentially bringing the company a few billion dollars ...
Medications
Mar 05, 2013 |
not rated yet |
0
India rejects Bayer plea against cheap cancer drug (Update)
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting ...
Medications
Mar 05, 2013 |
5 / 5 (4) |
3
Eli Lilly 2013 profit forecast tops expectations
(AP)—Eli Lilly and Co. said Friday its 2013 earnings will grow more than Wall Street expects, even though the drugmaker will lose U.S. patent protection for two more key products this year.
Other
Jan 04, 2013 |
not rated yet |
0
Ranbaxy recalls generic Lipitor doses
(AP)—Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once ...
Medications
Nov 23, 2012 |
not rated yet |
0
Bayer 'disappointed' after losing India patent fight
Pharmaceutical giant Bayer AG on Wednesday said it was "disappointed" with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and lung cancer.
Medications
Sep 26, 2012 |
not rated yet |
0
India generics giant wins cancer drug patent case
Indian generics giant Cipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over the Mumbai firm's version of a lung-cancer drug.
Medications
Sep 08, 2012 |
5 / 5 (4) |
2
Who pays for personalized medicine?
While researchers are busy identifying new biomarkers to detect disease and tailor treatments to individual needs, legal battles have been waged all the way up to the Supreme Court, trying to sort out whether a private company ...
Health
May 24, 2012 |
not rated yet |
0
Supreme Court ruling supports generic drug makers
The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.
Medications
Apr 18, 2012 |
5 / 5 (1) |
0
US Supreme Court rejects blood monitoring patents
Biotechnology industry officials are warning that a US Supreme Court ruling on patent rights this week could have a chilling effect on the development of personalized medicine.
Other
Mar 21, 2012 |
5 / 5 (1) |
1
India licenses generic copy of patented Bayer drug
(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.
Medications
Mar 12, 2012 |
5 / 5 (4) |
0
With new generic rivals, Lipitor's sales halved
Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.
Medications
Dec 20, 2011 |
not rated yet |
3
